Cormorant Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Cormorant Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$11.5M	Sell
2025 Q1	$20.1M	Sell
2024 Q4	$51.1M	Sell
2024 Q3	$56.2M	Sell
2024 Q2	$60.5M	Buy
2024 Q1	$53.8M	Hold
2023 Q4	$40.9M	Buy
2023 Q3	$32.8M	Buy